Vanguard Group Inc Aclaris Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,685,498 shares of ACRS stock, worth $18.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,685,498

Previous 4,687,551 0.04%

Holding current value

$18.6 Million

Previous $5.16 Million 2.68%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.12 - $1.4 $2,299 - $2,874	-2,053 Reduced 0.04%	4,685,498 $5.29 Million
Q2 2024 Aug 13, 2024	SELL	$1.01 - $1.36 $244,646 - $329,424	-242,224 Reduced 4.91%	4,687,551 $5.16 Million
Q1 2024 May 10, 2024	BUY	$0.92 - $1.44 $190,824 - $298,681	207,418 Added 4.39%	4,929,775 $6.11 Million
Q4 2023 Feb 14, 2024	BUY	$0.64 - $6.49 $869,959 - $8.82 Million	1,359,311 Added 40.42%	4,722,357 $4.96 Million
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $219,641 - $366,627	33,482 Added 1.01%	3,363,046 $23 Million
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $1.08 Million - $1.46 Million	137,138 Added 4.3%	3,329,564 $34.5 Million
Q1 2023 Jul 14, 2023	BUY	$7.07 - $17.95 $3,322 - $8,436	470 Added 0.01%	3,192,426 $25.8 Million
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $492,786 - $1.25 Million	69,701 Added 2.23%	3,191,956 $25.8 Million
Q4 2022 Feb 10, 2023	BUY	$14.33 - $18.37 $2.73 Million - $3.5 Million	190,546 Added 6.5%	3,122,255 $49.2 Million
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $1.54 Million - $2.15 Million	118,024 Added 4.19%	2,931,709 $46.1 Million
Q2 2022 Aug 12, 2022	BUY	$10.16 - $17.08 $862,228 - $1.45 Million	84,865 Added 3.11%	2,813,685 $39.3 Million
Q1 2022 May 13, 2022	BUY	$9.74 - $17.92 $104,344 - $191,976	10,713 Added 0.39%	2,728,820 $47 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $480,579 - $724,197	39,167 Added 1.46%	2,718,107 $39.5 Million
Q3 2021 Nov 12, 2021	BUY	$13.38 - $18.8 $1.5 Million - $2.11 Million	112,169 Added 4.37%	2,678,940 $48.2 Million
Q2 2021 Aug 13, 2021	BUY	$17.08 - $29.6 $43.8 Million - $76 Million	2,566,771 New	2,566,771 $45.1 Million

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $264M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Aclaris Therapeutics, Inc. Transaction History